Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

alpha-methyl-4-phosphonophenylglycine

Known as: MPPG cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
PURPOSE A fast-rotating O-ring dedicated intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) delivery… Expand
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
2001
2001
H]LY341495 is a highly potent and selective antagonist for group II metabotropic glutamate (mGlu) receptors (mGlu2 and mGlu3… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Highly Cited
2000
Highly Cited
2000
Glutamatergic innervation of the ventral tegmental area (VTA) and the nucleus accumbens (NA) regulates locomotor activity. The… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1996
1996
The metabotropic glutamate receptor (mGluR) agonists CCG-I and L-AP4, acting at Group II and Group III mGluRs respectively, can… Expand